Identification of a novel two-peptide lantibiotic, Haloduracin, produced by the alkaliphile Bacillus halodurans C-125

FEMS Microbiology Letters

Volumn 267, Issue 1, 2007, Pages 64-71

  Lawton, Elaine M ^a   Cotter, Paul D ^a   Hill, Colin ^a,b   Ross, R Paul ^b,c  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

^c TEAGASC   (Ireland)

Author keywords

Bacillus halodurans; Haloduracin; Two peptide lantibiotic

Indexed keywords

ANTIINFECTIVE AGENT; HALODURACIN; LANTIBIOTIC; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACILLUS; BACTERIAL STRAIN; BIOINFORMATICS; DRUG MANUFACTURE; DRUG TRANSPORT; GENE IDENTIFICATION; GENE SEQUENCE; GENETIC CODE; GENOME; GRAM POSITIVE BACTERIUM; IMMUNITY; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; SEQUENCE HOMOLOGY; SITE DIRECTED MUTAGENESIS; STRAIN IDENTIFICATION;

AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; ANTIBIOSIS; BACILLUS; BACTERIOCINS; COMPUTATIONAL BIOLOGY; GENE ORDER; GENES, BACTERIAL; GENOME, BACTERIAL; GRAM-POSITIVE BACTERIA; MASS SPECTROMETRY; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MULTIGENE FAMILY; MUTAGENESIS, SITE-DIRECTED; PEPTIDES;

BACILLUS HALODURANS; BACILLUS HALODURANS C-125; BACILLUS SP.; BACTERIA (MICROORGANISMS); POSIBACTERIA;

EID: 33846069684     PISSN: 03781097     EISSN: 15746968     Source Type: Journal    
DOI: 10.1111/j.1574-6968.2006.00539.x     Document Type: Article

References (32)

1. Arnaud M, Chastanet A & Debarbouille M(2004) New vector for efficient allelic replacement in naturally nontransformable, low-GC-content, gram-positive bacteria. Appl Environ Microbiol 70: 6887-6891.
2. Bonelli RR, Schneider T, Sahl HG &Wiedemann I (2006) Insights into in vivo activities of lantibiotics from gallidermin and epidermin mode-of-action studies. Antimicrob Agents Chemother 50: 1449-1457.
3. Booth MC, Bogie CP, Sahl HG, Siezen RJ, Hatter KL & Gilmore MS (1996) Structural analysis and proteolytic activation of Enterococcus faecalis cytolysin, a novel lantibiotic. Mol Microbiol 21: 1175-1184.
4. Chatterjee C, Paul M, Xie L & van der Donk WA (2005) Biosynthesis and mode of action of lantibiotics. Chem Rev 105: 633-684.
5. Cotter PD, Hill C & Ross RP (2005a) Food microbiology bacteriocins: developing innate immunity for food. Nat Rev Microbiol 3: 777-788.
6. Cotter PD, O'Connor PM, Draper LA, Lawton EM, Deegan LH, Hill C & Ross RP (2005b) Posttranslational conversion of L-serines to D-alanines is vital for optimal production and activity of the lantibiotic lacticin 3147. Proc Natl Acad Sci USA 102: 18584-18589.
7. Cotter PD, Deegan L, Lawton EM, Draper LA, O'Connor PM, Hill C & Ross RP (2006a) Complete alanine scanning of the two-component lantibiotic lacticin 3147: generating a blueprint for rational drug design. Mol Microbiol 62: 735-747.
8. Cotter PD, Draper LA, Lawton EM, McAuliffe O, Hill C & Ross RP (2006b) Overproduction of wild-type and bioengineered derivatives of the lantibiotic lacticin 3147. Appl Environ Microbiol 72: 4492-4496.
9. de Hoon MJ, Makita Y, Nakai K & Miyano S (2005) Prediction of transcriptional terminators in Bacillus subtilis and related species. PLoS Comput Biol 1: e25.
10. Galvin M, Hill C & Ross RP (1999) Lacticin 3147 displays activity in buffer against gram-positive bacterial pathogens which appear insensitive in standard plate assays. Lett Appl Microbiol 28: 355-358.
11. Gasson MJ (1983) Plasmid complements of Streptococcus lactis NCDO 712 and other lactic streptococci after protoplast-induced curing. J Bacteriol 154: 1-9.
12. Holo H, Jeknic Z, Daeschel M, Stevanovic S & Nes IF (2001) Plantaricin W from Lactobacillus plantarum belongs to a new family of two-peptide lantibiotics. Microbiology 147: 643-651.
13. Horikoshi K (1999) Alkaliphiles: some applications of their products for biotechnology. Microbiol Mol Biol Rev 63: 735-750.
14. Hyink O, Balakrishnan M & Tagg JR (2005) Streptococcus rattus strain BHT produces both a class I two-component lantibiotic and a class II bacteriocin. FEMS Microbiol Lett 252: 235-241.
15. Kiriukhin MY, Debabov DV, Shinabarger DL & Neuhaus FC (2001) Biosynthesis of the glycolipid anchor in lipoteichoic acid of Staphylococcus aureus RN4220: role of YpfP, the diglucosyldiacylglycerol synthase. J Bacteriol 183: 3506-3514.
16. Klaenhammer TR (1993) Genetics of bacteriocins produced by lactic acid bacteria. FEMS Microbiol Rev 12: 39-85.
17. Law J, Buist G, Haandrikman A, Kok J, Venema G & Leenhouts K (1995) A system to generate chromosomal mutations in Lactococcus lactis which allows fast analysis of targeted genes. J Bacteriol 177: 7011-7018.
18. Leenhouts K, Buist G, Bolhuis A, ten Berge A, Kiel J, Mierau I, Dabrowska M, Venema G & Kok J (1996) A general system for generating unlabelled gene replacements in bacterial chromosomes. Mol Gen Genet 253: 217-224.
19. Maguin E, Duwat P, Hege T, Ehrlich D & Gruss A (1992) New thermosensitive plasmid for gram-positive bacteria. J Bacteriol 174: 5633-5638.
20. Majer F, Schmid DG, Altena K, Bierbaum G & Kupke T (2002) The flavoprotein MrsD catalyzes the oxidative decarboxylation reaction involved in formation of the peptidoglycan biosynthesis inhibitor mersacidin. J Bacteriol 184: 1234-1243.
21. Martin NI, Sprules T, Carpenter MR, Cotter PD, Hill C, Ross RP & Vederas JC (2004) Structural characterization of lacticin 3147, a two-peptide lantibiotic with synergistic activity. Biochemistry 43: 3049-3056.
22. McAuliffe O, Ryan MP, Ross RP, Hill C, Breeuwer P & Abee T (1998) Lacticin 3147, a broad-spectrum bacteriocin which selectively dissipates the membrane potential. Appl Environ Microbiol 64: 439-445.
23. McAuliffe O, Hill C & Ross RP (2000) Each peptide of the two-component lantibiotic lacticin 3147 requires a separate modification enzyme for activity. Microbiology 146: (Part 9): 2147-2154.
24. Morgan SM, O'Connor PM, Cotter PD, Ross RP & Hill C (2005) Sequential actions of the two component peptides of the lantibiotic lacticin 3147 explain its antimicrobial activity at nanomolar concentrations. Antimicrob Agents Chemother 49: 2606-2611.
25. Navaratna MA, Sahl HG & Tagg JR (1998) Two-component anti-Staphylococcus aureus lantibiotic activity produced by Staphylococcus aureus C55. Appl Environ Microbiol 64: 4803-4808.
26. Pag U, Heidrich C, Bierbaum G & Sahl HG (1999) Molecular analysis of expression of the lantibiotic pep5 immunity phenotype. Appl Environ Microbiol 65: 591-598.
27. Ryan MP, Rea MC, Hill C & Ross RP (1996) An application in cheddar cheese manufacture for a strain of Lactococcus lactis producing a novel broad-spectrum bacteriocin, lacticin 3147. Appl Environ Microbiol 62: 612-619.
28. Ryan MP, Jack RW, Josten M, Sahl HG, Jung G, Ross RP & Hill C (1999) Extensive post-translational modification, including serine to D-alanine conversion, in the twocomponent lantibiotic, lacticin 3147. J Biol Chem 274: 37544-37550.
29. Smith L, Novak J, Rocca J, McClung S, Hillman JD & Edison AS (2000) Covalent structure of mutacin 1140 and a novel method for the rapid identification of lantibiotics. Eur J Biochem 267: 6810-6816.
30. Stein T (2005) Bacillus subtilis antibiotics: structures, syntheses and specific functions. Mol Microbiol 56: 845-857.
31. Takami H, Nakasone K, Takaki Yet al. (2000) Complete genome sequence of the alkaliphillic bacterium Bacillus halodurans C-125 and genomic sequence comparison with Bacillus subtilis. Nucleic Acid Res 28: 4317-4331.
32. Yonezawa H & Kuramitsu HK (2005) Genetic analysis of a unique bacteriocin, Smb, produced by Streptococcus mutans GS5. Antimicrob Agents Chemother 49: 541-548.